对移植不合格的患者进行突变和MRD信息的治疗
Curtis A Lachowiez1, Courtney D DiNardo2
1Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR.
Hematology. American Society of Hematology. Education Program
|December 7, 2024
概括
像阿扎西蒂丁和维内托克拉克斯 (AZA-VEN) 这样的新疗法正在改善老年急性髓性白血病 (AML) 患者的治疗结果. 研究正在确定耐药性机制,并开发新的向治疗方法,以改善AML患者的生存率.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 老年,不适合移植的急性髓性白血病 (AML) 患者传统上面临着传统化疗的不良预后.
- 随着新的治疗方案的推出,护理标准发生了变化,包括阿扎西蒂丁和维内托克拉克斯 (AZA-VEN).
研究的目的:
- 审查AML治疗中最近的进展,用于移植不合格的患者.
- 总结针对性疗法和AZA-VEN对患者结果和生存的影响.
主要方法:
- 关于AML治疗策略的当前文献的审查.
- 对新型治疗组合的临床试验数据的分析.
- 检查抵抗机制和风险分层模型.
主要成果:
- 在选择的AML患者亚组中,AZA-VEN和向疗法显示出持久的缓解.
- 识别耐药机制有助于开发新的风险模型和临床试验.
- 早期试验表明HMA-VEN与IDH1/2,FLT3和脑膜抑制剂结合的安全性和有效性.
结论:
- 分子向疗法和AZA-VEN已经改变了对老年,不适合移植的患者的AML治疗.
- 对抗药性机制和新组合的持续研究有望进一步改善AML的结果.
- 可测量的残留疾病监测可以提高预后,并允许对AML进行早期干预.
相关概念视频
Bone Marrow Sampling and Transplants
284
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
284
Tissue Transplantation
338
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
338
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K


